Industry Briefs: October 29, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.
Company News
AnGes has entered into a definitive agreement with Mitsubishi Tanabe Pharma for the exclusive marketing rights of Collategene (DNA plasmid with hepatocyte growth factor gene) for treating for peripheral arterial disease in the United States.
DSM Pharmaceutical Products has announced a biologics development and manufacturing agreement with Paranta Biosciences, for Paranta’s lead recombinant human protein for DSM’s at their Brisbane, Australia, facility.
People News
Coldstream Laboratories has appointed Eric W. Smart as president and CEO.
Eli Lilly has named Melissa Barnes as chief ethics and compliance officer, and senior vice-president. Barnes will replace Anne Nobles, following her retirement at the end of 2012.
Spectrum Pharmaceuticals has appointed Joseph Turgeon as senior vice-president of sales and commercial operations.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
